NEW YORK (GenomeWeb) – Novacyt today announced it has raised €2 million ($2.2 million) in private financing. 

Participants in the round included current investors Alto Invest and Nyenburgh. The firm said that investors in the round will receive 399,500 new shares of Novacyt. Proceeds will be used to expand sales of the NovaPrep liquid-based cytology platform, particularly in international markets, and to support the introduction of a reagent rental policy for NovaPrep instrument placements. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.